Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 1467 entries
View as:

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Phase: N/A Priority: Normal
NCT ID: NCT04684524 Org: User:
Start: 12/01/20 End: 03/07/25 Due: 03/07/26

Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

Phase: N/A Priority: Normal
NCT ID: NCT05671770 Org: User:
Start: 07/28/23 End: 12/14/23 Due: 12/14/24

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

Phase: N/A Priority: Normal
NCT ID: NCT01122979 Org: User:
Start: 07/31/10 End: 10/31/13 Due: 10/31/14

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT04781816 Org: User:
Start: 04/01/21 End: 06/26/23 Due: 06/26/24

Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00786097 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01593228 Org: User:
Start: 05/31/12 End: 09/30/16 Due: 09/30/17

Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)

Phase: N/A Priority: Normal
NCT ID: NCT00357149 Org: User:
Start: 01/31/03 End: - Due: -

AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00719524 Org: User:
Start: 07/31/08 End: 02/28/13 Due: 02/28/14

ALF-ONE : ALFuzosin ONcE Daily

Phase: N/A Priority: Normal
NCT ID: NCT00280605 Org: User:
Start: 08/31/05 End: 02/28/06 Due: 02/28/07

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

Phase: N/A Priority: Normal
NCT ID: NCT00032747 Org: User:
Start: 08/31/01 End: 02/28/03 Due: 02/28/04

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT06241118 Org: User:
Start: 02/29/24 End: 06/30/26 Due: 06/30/27

A Study of SAR428926 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02575781 Org: User:
Start: 10/05/15 End: 06/30/18 Due: 06/30/19

Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo

Phase: N/A Priority: Normal
NCT ID: NCT02585674 Org: User:
Start: 12/31/15 End: 11/30/16 Due: 11/30/17

Ramipril - Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00325806 Org: User:
Start: 05/31/00 End: 08/31/05 Due: 08/31/06

Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00359437 Org: User:
Start: 07/31/06 End: 10/31/08 Due: 10/31/09

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01021150 Org: User:
Start: 03/31/10 End: 05/31/11 Due: 05/31/12

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

Phase: N/A Priority: Normal
NCT ID: NCT06293053 Org: User:
Start: 05/15/24 End: 11/03/27 Due: 11/03/28

A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Phase: N/A Priority: Normal
NCT ID: NCT06500702 Org: User:
Start: 12/19/24 End: 02/16/28 Due: 02/16/29

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05039840 Org: User:
Start: 11/10/21 End: 10/02/26 Due: 10/02/27

Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01169779 Org: User:
Start: 07/31/10 End: 12/31/11 Due: 12/31/12

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Phase: N/A Priority: Normal
NCT ID: NCT00663325 Org: User:
Start: 12/31/07 End: - Due: -

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00252330 Org: User:
Start: 09/30/05 End: 01/31/07 Due: 01/31/08

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Phase: N/A Priority: Normal
NCT ID: NCT00355121 Org: User:
Start: 10/31/06 End: 07/31/09 Due: 07/31/10

Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01129388 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00087958 Org: User:
Start: 08/31/04 End: 04/30/09 Due: 04/30/10